Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0001415889-24-003043

Director acquired 3,180,155 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
RA CAPITAL MANAGEMENT, L.P. Director 2024-02-06 Grant or award +3,180,155 $13.01 $41,373,817 8,477,275 I
Derivatives
RA CAPITAL MANAGEMENT, L.P. Director 2024-02-06 Grant or award · Pre-Funded Warrants (Right to Buy) +1,538,457 $13.01 $20,013,787 1,538,457 I
Loading xslF345X05/form4-02082024_100255.xml…